Hepion Pharmaceuticals, Inc.
HEPA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $12 | $36 | $33 | $20 |
| G&A Expenses | $7 | $10 | $10 | $10 |
| SG&A Expenses | $7 | $10 | $10 | $10 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $3 | $2 | $0 |
| Operating Expenses | $19 | $48 | $45 | $30 |
| Operating Income | -$19 | -$48 | -$45 | -$30 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $3 | -$1 | $0 | -$2 |
| Pre-Tax Income | -$16 | -$49 | -$45 | -$33 |
| Tax Expense | -$3 | -$0 | -$3 | $0 |
| Net Income | -$13 | -$49 | -$42 | -$33 |
| % Margin | – | – | – | – |
| EPS | -107.348 | -616.072 | -594.75 | -465.52 |
| % Growth | 82.6% | -3.6% | -27.8% | – |
| EPS Diluted | -107.348 | -616.072 | -594.75 | -465.52 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$15 | -$49 | -$45 | -$33 |
| % Margin | – | – | – | – |